Select Page

International Directory of Plasma Fractionators – 2020

 

Announcement

INTERNATIONAL DIRECTORY OF PLASMA FRACTIONATORS 2020
& Forecast to 2030

The report entitled International Directory of Plasma Fractionators 2020 & Forecast to 2030 is now available. It updates our 2018 report with a complete listing of the major commercial and non-profit organizations that front fractionate human plasma into therapeutic proteins in each region and globally. The following data are provided for each fractionation plant, when available, (over 75 in total):

•   Fractionation capacity, throughput and utilization
•   Type of Plasma Fractionated (Recovered vs Source).
•   Legal status (Parent Owner for each plant), and
•   Contact Information (address, email and website),

Together, this information is analyzed to create a global comparison of fractionation plants, their capacity, throughput and utilization by company and region.

The forecast is based on the 2020 global information and uses the Marketing Research Bureau’s extensive industry contacts and primary research to create estimates of the fractionation capacities and throughputs of all the fractionation plants globally to the year 2030, starting with historical data from 2016. This helps the reader understand the expected growth of the industry on a company and regional basis, along with future throughput and plasma production volumes for key products.

THE INTERNATIONAL DIRECTORY OF PLASMA FRACTIONATORS — 2020

TABLE OF CONTENTS of the Current Report

EXECUTIVE SUMMARY

INTRODUCTION: BACKGROUND & METHODOLOGY

FRACTIONATION PLANT CAPACITIES IN 2020

Regional Distribution of Plants & Front Fractionation Capacity
Largest Fractionators by Capacity in 2020

FRACTIONATION PLANT THROUGHPUT & UTILIZATION IN 2020

Regional Distribution of Plasma Throughput & Plant Utilization
Largest Fractionators by Throughput in 2020
Type of Plasma Fractionated (Source vs. Recovered)

FRACTIONATION CAPACITY AND THROUGHPUT FORECAST TO 2030

FORECAST ASSUMPTIONS

Impact of Economic Fluctuations on Individual Company Forecasts
Regional Fractionation Throughput
No Acquisitions or Permanent Closures of Plants Assumed in Forecast
Utilization Rates & Preferences
Immunoglobulin Demand and Plasma Collection Trends

FORECAST OF FRACTIONATION PLANT THROUGHPUT TO 2030

Forecast of the Largest Fractionators by Throughput in 2030
Origin of Plasma for Fractionation

FORECAST OF FRACTIONATION PLANT CAPACITIES & UTILIZATION TO 2030

Forecast of the Largest Fractionators by Capacity
Forecast of Regional Distribution of Front Fractionation Capacity
New Government or National Fractionation Plants to Support Local Product Needs

THERAPEUTIC PLASMA PROTEINS PRODUCTION FORECAST

NORTH AMERICA PLANT PROFILES

EUROPE PLANT PROFILES

ASIA & PACIFIC PLANT PROFILES

CHINA PLANT PROFILES

MIDDLE EAST & AFRICA PLANT PROFILES

LATIN AMERICA PLANT PROFILES

SAMPLE PAGE

COUNTRY                               ZZZZ

NAME                                      XYZ PHARMACEUTICAL CO.

ADDRESS                                 111 MAIN ROAD

CITY                                        AAA

STATE/POSTAL CODE             000 BBBB

TELEPHONE                           +86 111 0000 1234

EMAIL                                     ABCD@gmail.com

WEBSITE                                 www.xyz.com

CHIEF EXECUTIVE OFFICER           XXX

OWNERSHIP           ABCDE HOLDING

STATUS                      COMMERCIAL

NUMBER OF EMPLOYEES                                                                 

(PLASMA DERIVATIVES PRODUCTION & SALES)                                              0,000

PLANT CAPACITY
(LITERS X 000)
                            00

PLASMA PROCESSED (LITERS X 000)                                           

PLASMAPHERESIS                      000

RECOVERED PLASMA                000

TOTAL LITERS FRACTIONATED     000

MAIN PRODUCTS   ALBUMIN, IVIG, IMIG, FACTOR VIII, FACTOR IX, PCC

NEW PRODUCTS INTRODUCED SINCE 2018:              Any New Products